RELAPSED MULTIPLE MYELOMA
Clinical trials for RELAPSED MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSED MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat myeloma: experimental drug enters human trials
Disease control Recruiting nowThis early-stage trial tests a new drug called OPN-6602, alone or with a steroid, in 130 people whose multiple myeloma has returned or stopped responding to at least three prior treatments. The main goal is to check safety and find the right dose. It's too early to know if it wil…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Opna Bio LLC • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for Hard-to-Treat myeloma: drug combo trial launches
Disease control Recruiting nowThis early-phase trial tests a combination of three drugs—talquetamab, iberdomide, and dexamethasone—in people with multiple myeloma that has returned or stopped responding to prior treatments. The goal is to find the safest dose and check for side effects. About 32 adults will t…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Alfred Chung, MD • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New Four-Drug cocktail aims to crush resistant myeloma
Disease control Recruiting nowThis phase 2 trial is testing whether a combination of four drugs—iberdomide, daratumumab, carfilzomib, and dexamethasone—can shrink or prevent the return of multiple myeloma in patients whose cancer has relapsed or stopped responding to prior treatments. About 30 participants wi…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: Benjamin T Diamond, MD • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can extra antibodies keep myeloma patients safer on powerful new drugs?
Disease control Recruiting nowThis study looks at whether giving extra antibodies (immunoglobulins) can help prevent serious infections in people with multiple myeloma who are being treated with a new kind of immunotherapy called a BCMA-directed T cell engager. About 80 adults who have already tried at least …
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE4 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC